Cyclerion Therapeutics In...
3.00
0.08 (2.74%)
At close: Jan 15, 2025, 2:41 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue n/a 297.00K 3.32M 2.30M 4.51M n/a n/a n/a
Cost of Revenue n/a 65.00K 472.00K n/a n/a 1.53M 1.75M 2.17M
Gross Profit n/a 232.00K 2.85M 2.30M 4.51M -1.53M -1.75M -2.17M
Operating Income -9.65M -44.37M -55.20M -81.27M -125.04M -115.25M -93.92M -63.55M
Interest Income 358.00K 294.00K n/a 588.00K 2.03M n/a n/a n/a
Pretax Income -12.59M -44.08M -51.65M -77.80M -123.01M -115.25M -93.92M -63.55M
Net Income -21.02M -43.78M -51.66M -72.67M -120.98M -115.25M -93.92M -63.55M
Selling & General & Admin 8.13M 14.50M 20.62M 28.82M 34.40M 27.54M 15.12M 10.48M
Research & Development 1.51M 31.49M 37.64M 56.41M 95.14M 87.72M 78.80M 50.90M
Other Expenses n/a -1.33M -622.00K n/a n/a n/a n/a n/a
Operating Expenses 9.65M 44.67M 57.63M 85.23M 129.54M 115.25M 93.92M 61.38M
Interest Expense n/a 294.00K 16.00K n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 9.65M 44.67M 57.63M 85.23M 129.54M 115.25M 93.92M 63.55M
Income Tax n/a -294.00K 16.00K -5.13M -2.03M 1.37M n/a n/a
Shares Outstanding (Basic) 2.34M 2.17M 1.96M 1.52M 1.37M 1.37M 1.37M 1.37M
Shares Outstanding (Diluted) 2.34M 2.17M 1.96M 1.52M 1.37M 1.37M 1.37M 1.37M
EPS (Basic) -8.99 -20.15 -26.4 -47.8 -88.37 -84.42 -68.8 -46.39
EPS (Diluted) -8.99 -20.15 -26.4 -47.8 -88.37 -84.42 -68.8 -46.39
EBITDA -12.59M -18.18M -55.20M -81.27M -122.34M -113.72M -92.18M -61.38M
Depreciation & Amortization -2.95M 65.00K 472.00K 2.30M 2.70M 1.53M 1.75M 2.17M